Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1674867Erstellt: 25. Oktober 2026

Quinoxaline-5-carbaldehyde → 5-[[4-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazin-1-yl]methyl]quinoxaline

https://huagongshe.com/reaction/1674867

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktQuinoxaline-5-carbaldehydeHCID 582505—
Edukt6-Piperazino-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazineHCID 1476862—
Produkt5-[[4-[3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazin-1-yl]methyl]quinoxalineHCID 67340878—

Reaktionsschritte

Reductive amination of 6-(piperazin-1-yl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine with quinoxaline-5-carbaldehyde was carried out according to General Synthetic Method 7. The crude product was purified by hplc using a Waters XBridge Prep C18 OBD column, 5μ silica, 21 mm diameter, 100 mm length eluted with decreasingly polar mixtures of water (containing 0.05% aqueous ammonia) and acetonitrile as eluents to give 5-[[4-[3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazin-1-yl]methyl]quinoxaline.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08003649B2
Quelldatensatzuspto-grants-2011_08
ORD IDord-1631ca2dd63b403a95d5e64d8fd0275f
Quellennotizuspto-grants-2011_08